SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Gynecologic Oncology Consultation — Ada Lovelace

PatientAda Lovelace
Date of birth1990-12-10
IdentifiersMRN HR-NI031-SYN; SSN (made up) 000-31-6729
Document date2026-06-16
AuthorBeatrix Lindgren-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Friable exophytic cervical mass with five months of abnormal bleeding and constant pelvic pain in a 35-year-old woman, biopsied today, with iron deficiency anemia. Please confirm the diagnosis, stage the disease, advise on treatment intent and options, and help with control of bleeding and pain. [S]

Urgency: Within two weeks; pathology expected within a week. [S]

Questions for the consultant:

History of Present Illness

Mrs. Lovelace, a 35-year-old mathematician, is seen at the request of Dr. Whitley-Adeyemi for a cervical mass found two weeks ago after five months of abnormal bleeding and pelvic pain. The bleeding is lighter since the first iron infusion but continues. Her pain averages 6 of 10 on oral morphine solution 5 mg about six times a day, without drowsiness; she stopped the opium tincture she had taken for two years. She has no cough, hemoptysis, bone pain, leg swelling, or urinary or bowel symptoms beyond opioid-related constipation. She has never had cervical screening. She does not wish to preserve fertility. She asked to be told the findings directly. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Opium tincture (100 mg/mL opium, equivalent to 10 mg/mL morphine), 0.5 mL by mouth four to six times a day as needed for pain0.5 mL four to six times a day as neededOral route2024-06-03 to 2026-06-02completedS
Morphine sulfate oral solution 2 mg/mL, 5 mg (2.5 mL by oral syringe) every 4 hours as needed for pain5 mg every 4 hours as neededOral route2026-06-02activeS
Morphine sulfate extended-release 15 mg tablet, one tablet by mouth every 12 hours; swallow wholeevery 12 hoursOral route2026-06-16 to 2026-10-20completedS
Naloxone 4 mg nasal spray, one spray in a nostril for suspected opioid overdose; call 911one spray as needed for suspected overdose; repeat after 2 to 3 minutes if neededNasal route2026-06-02activeS
Senna 8.6 mg tablet, two tablets by mouth at nighttwo tablets at nightOral route2026-06-02activeS
Polyethylene glycol 3350, 17 g in water by mouth once or twice a dayonce daily, up to twice dailyOral route2026-06-02activeS
Acetaminophen 500 mg tablet, two tablets by mouth three times a day1 g three times a dayOral route2026-06-02activeS
Ferric carboxymaltose 750 mg intravenous infusion, two doses at the first two visits750 mg on two occasions two weeks apartIntravenous route2026-06-02 to 2026-06-17completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Bleeding between periods and after intercourse, with heavier periods, a watery blood-stained discharge and a constant pelvic ache, for about five months; average pain 7 of 10 despite her opium tincture; a friable cervical mass found on examination and biopsied; cause not yet established at intakeresolvedconfirmed N93.8S — Synthetic presenting problem anchored to her documented final illness; superseded by the diagnosis at the second visit.
Iron deficiency anemia from chronic blood loss: hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, with tiredness and breathlessness on stairsactiveconfirmed D50.0S — Synthetic modern finding anchored to her documented final illness.
Adenocarcinoma of the endocervix, usual (HPV-associated) type, HPV 18 positive, FIGO 2018 stage IVB: a 5.2 cm tumor with left parametrial invasion, metastases to left pelvic and para-aortic lymph nodes, and bilateral lung metastases on MRI and PET-CT; PD-L1 combined positive score 5, mismatch repair proficient, HER2 1+; treated with palliative pelvic radiation for bleeding and carboplatin, paclitaxel and pembrolizumab, with specialist palliative care from diagnosisactiveconfirmed C53.0S — Synthetic modern diagnosis made at the second visit, anchored to her documented uterine cancer; the cervical site is a synthetic choice.
Cancer-related pelvic pain, nociceptive and visceral, from the cervical tumor and its left parametrial extensionactiveconfirmed G89.3S — Synthetic modern diagnosis made at the second visit.
Long-term prescribed opioid therapy: opium tincture for recurrent pelvic and abdominal pain for about two years, measured at times with a household spoon, converted at intake to measured oral morphine; no opioid use disorder on a DSM-5 assessment; naloxone suppliedactiveconfirmed Z79.891S — Synthetic modern history anchored to her documented laudanum and opium; not a claim about her real dosing.

Physical Exam

Vital signs recorded on 2026-06-16; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralPale, alert, not sedated; blood pressure 106/66, pulse 92; ECOG performance status 1
Lymph nodesNo supraclavicular or inguinal lymph node enlargement
AbdomenSoft; mild suprapubic tenderness; no masses
PelvisExophytic friable cervical tumor about 5 cm with light bleeding; left parametrial thickening not reaching the sidewall; vagina free; rectovaginal septum free

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-16Hemoglobin [Mass/volume] in Blood9g/dL12-15.5 g/dLLowS
2026-06-16Creatinine [Mass/volume] in Serum or Plasma0.66mg/dL0.57-1 mg/dLNormalS
2026-06-16Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma17U/L7-35 U/LNormalS
2026-06-16Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-06-16Thyroxine (T4) free [Mass/volume] in Serum or Plasma1.2ng/dL0.8-1.8 ng/dLNormalS
2026-06-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M117mL/min/{1.73_m2}60 or moreNormalS
2026-06-16Pain severity - 0-10 verbal numeric rating [Score] - Reported6{score}S

Assessment

Data reviewed: Cervical biopsy: invasive adenocarcinoma, usual (HPV-associated) type, p16 diffusely positive, HPV 18 detected; PD-L1 combined positive score 5; mismatch repair proteins retained; HER2 immunohistochemistry 1+. Pelvic MRI a week ago: 5.2 cm endocervical tumor with left parametrial invasion, not reaching the sidewall, no hydronephrosis, an enlarged left external iliac node. FDG PET-CT five days ago: avid tumor, avid left pelvic and para-aortic nodes, six avid nodules in both lungs up to 1.4 cm, no bone or liver lesions. Hemoglobin 9.0 g/dL today, from 8.4; creatinine 0.66 mg/dL; ALT 17 U/L; TSH 1.9 mIU/L; HIV, hepatitis B and hepatitis C tests negative. [S]

Plan of Treatment